EcoDrugPlus

Matrix Metallopeptidase 9

Ensembl ID : ENSXMAG00000010153
Gene Symbol: MMP9
3 Cross references
215 Possible Orthologues:

Matrix Metalloproteinase-14

Ensembl ID : ENSXMAG00000001547
Gene Symbol: LOC102236856
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSXMAG00000000903
Gene Symbol: LOC102236291
3 Cross references
196 Possible Orthologues:

Matrix Metalloproteinase-18-Like

Ensembl ID : ENSXMAG00000026504
Gene Symbol: LOC102222192
2 Cross references
231 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSXMAG00000001558
Gene Symbol: LOC102216680
2 Cross references
163 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSXMAG00000013339
Gene Symbol: MTOR
1 Cross references
215 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSXMAG00000001373
Gene Symbol: MTOR
1 Cross references
215 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSXMAG00000003026
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000024200
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000024921
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000025828
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000020988
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).